Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients

Renal Failure

Volumn 34, Issue 7, 2012, Pages 849-855

  Knezevic, Marinela Z ^a   Djordjevic, Vladimir V ^b   Radovanovic Velickovic, Radmila M ^b   Stankovic, Jablan J ^b   Cvetkovic, Tatjana P ^c   Djordjevic, Vidojko M ^b  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b Clinical Centre Nis   (Serbia)

^c UNIVERSITY OF NI   (Serbia)

Author keywords

hemodiafiltration; hemodialysis; high flux membrane; low flux membrane; quality of life

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH FLUX HEMODIALYSIS HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; LOW FLUX HEMODIALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; POLYMERS; QUALITY OF LIFE; REGRESSION ANALYSIS; RENAL DIALYSIS; SULFONES;

EID: 84863882007     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.684555     Document Type: Article

References (39)

1. Khan IH, Garratt AM, Kumar A, et al. Patient's perception of health on renal replacement therapy: Evaluation using a new instrument. Nephrol Dial Transplant. 1995;10:684-689.
2. Procaccini DA, Angelini P, Aucella F, et al. Health-related quality of life in patients with chronic kidney disease. G Ital Nefrol. 2008;25:694-701.
3. Mazairac AH, de Wit GA, Penne EL, et al. Changes in quality of life over time - Dutch hemodialysis patients and general population compared. Nephrol Dial Transplant. 2011;26:1984-1989.
4. Lowrie EG, Curtin RB, LePain N, Schatell D. Medical outcomes study short form-36: A consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis. 2003;4:1286-1292. (Pubitemid 36637985)
5. Kušleikaitė N, Bumblytė IA, Kuzminskis V, Vaičiūnienė R. The association between health-related quality of life and mortality among hemodialysis patients. Medicina. 2010;46:531-537.
6. Ginieri-Coccossis M, Theofilou P, Synodinou C, Tomaras V, Soldatos C. Quality of life, mental health and health beliefs in hemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatment. BMC Nephrol. 2008;9:14.
7. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM. Quality-of-life evaluation using Short Form 36: Comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2000;35:293-300. (Pubitemid 30070852)
8. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-379.
9. Rambod M, Shabani M, Shokrpour N, Rafii F, Mohammadalliha J. Quality of life of hemodialysis and renal transplantation patients. Health Care Manag. 2011;30:23-28.
10. Theofilou P. Quality of life in patients undergoing hemodialysis and peritoneal dialysis treatment. J Clin Med Res. 2011;3:132-138.
11. Russo GE, Morgia A, Cavallini M, et al. Quality of life assessment in patients on hemodialysis and peritoneal dialysis. G Ital Nefrol. 2010;27:290-295.
12. Churcchill DN, Bird DR, Taylor DW, Beecroft ML, Gorman J, Wallace JE. Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol. 1992;12:412-418. (Pubitemid 23063770)
13. Unruh M, Benz R, Green T, et al. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int. 2004;66:355-366. (Pubitemid 38870113)
14. Drüeke TB. Beta2-microglobulin and amyloidosis. Nephrol Dial Transplant. 2000;15(Suppl. 1):17-24.
15. Canaud B, Krieter D. Hemodiafiltration and hemofiltration. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis. 4th ed., Philadelphia, PA: Lippincott Williams and Wilkins; 2007:265-275.
16. Leypoldt JK. Solute fluxes in different treatment modalities. Nephrol Dial Transplant. 2000;15(Suppl. 1):3-9. (Pubitemid 30114202)
17. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol. 2000;11:2344-2350.
18. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The registro lombardo dialisi E trapianto. Kidney Int. 1999;55:286-293. (Pubitemid 29004261)
19. Rabindranath KS, Strippoli GF, Daly C, Roderick PJ, Wallace S, MacLeod AM. Hemodiafiltration, hemofiltration and hemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2006;18:CD006258.
20. Lin CL, Huang CC, Chang CT, et al. Clinical improvement by increased frequency of on-line hemodiafiltration. Ren Fail. 2001;23:193-206.
21. Schiffl H. Prospective randomized cross-over long-term comparison of online hemodiafiltration and ultrapure high-flux hemodialysis. Eur J Med Res. 2007;12:26-33.
22. Cheung AK, Levin NW, Green T, et al. Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol. 2003;14:3251-3263. (Pubitemid 37509301)
23. Port FK, Wolfe RA, Hulbert-Shearon TE, et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis. 2001;37:276-286. (Pubitemid 32116018)
24. Locatelli F, Martin Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20:645-654.
25. Kreusser W, Reiermann S, Vogelbusch G, Bartual J, Schulze-Lohoff E. Effect of different synthetic membranes on laboratory parameters and survival in chronic hemodialysis patients. Nephrol Dial Transplant. 2010;3:i12-i19.
26. Koda Y, Nishi S, Miyazaki S, et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997;52:1096-1101. (Pubitemid 27435845)
27. Woods HF, Nandakumar M. Improved outcome for hemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant. 2000;15(Suppl. 1):36-42. (Pubitemid 30114208)
28. Eknoyan G, Beck GJ, Cheung AK, et al. Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010-2019. (Pubitemid 35461657)
29. Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant. 2007;22:ii5-ii21.
30. Tattersall J, Canaud B, Heimburger O, Pedrini L, Schneditz D, Biesen WV. European renal best practice advisory board. High-flux or low-flux dialysis: A position statement following publication of the membrane permeability outcome study. Nephrol Dial Transplant. 2010;25:1230-1232.
31. Basile C, Giordano R, Montanaro A. Effect of acetate-free biofiltration on the anemia of hemodialysis patients: A prospective cross-over study. Nephrol Dial Transplant. 2001;16:1914-1919. (Pubitemid 32821427)
32. Opatrný Jr K, Reischig T, Vienken J, et al. Does treatment modality have an impact on anemia in patients with chronic renal failure? Effect of low- and high-flux biocompatible dialysis. Artif Organs. 2002;26:181-188. (Pubitemid 34225216)
33. Ayli D, Ayli M, Azak A, et al. The effect of high-flux hemodialysis on renal anemia. J Nephrol. 2004;17:701-706. (Pubitemid 40484584)
34. Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD Patients: Correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4:1293-1301.
35. Fructuoso M, Castro R, Oliveira L, Prata C, Morgado T. Quality of life in chronic kidney disease. Nefrologia. 2011;31:91-96.
36. Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 2009;4:1057-1064.
37. Valderrábano F, Jofre R, López-Gómez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001;38:443-464. (Pubitemid 32803054)
38. Simic-Ogrizovic S, Jemcov T, Pejanovic S, Stosovic M, Radovic M, Djukanovic L. Health-related quality of life, treatment efficacy, and hemodialysis patient outcome. Ren Fail. 2009;31:201-206.
39. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry. 1994;151:979-986. (Pubitemid 24208631)